Harris & Harris Group Inc /ny/ (TINY): Phillip A Bauman , director of Harris & Harris Group Inc /ny/ purchased 2,861 shares on Mar 18, 2016. The Insider buying transaction was disclosed on Apr 4, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.91 per share for a total value of $5,464.80.
Currently the company Insiders own 5.3% of Harris & Harris Group shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by 0.56%.Institutional Investors own 34.56% of Harris & Harris Group shares.During last six month period, the net percent change held by insiders has seen a change of 3.55%.
Shares of Harris & Harris Group (TINY) ended Wednesday, Mar 30, 2016 session in red amid volatile trading. The shares closed down -0.05 points or -2.84% at $1.71 with 1,75,904 shares getting traded. Post opening the session at $1.75, the shares hit an intraday low of $1.7 and an intraday high of $1.7799 and the price vacillated in this range throughout the day. The company has a market cap of $53 M and the number of outstanding shares has been calculated to be 3,08,45,754 shares. The 52-week high of Harris & Harris Group is $3.15 and the 52-week low is $1.6.
Harris & Harris Group Inc. is a venture capital firm. The Firm is regulated as a business development company. Its investment objective is to achieve long-term capital appreciation by making venture capital investments. As a venture capital firm it invests in and provides managerial assistance to its portfolio companies. The Firm’s investment has two characteristics: early stage where its focus is on founding incubating and building transformative companies from disruptive science and BIOLOGY+ investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics physics materials science chemistry information technology engineering and mathematics.